Synapse

← HIV Therapy

Papers in HIV Therapy

Page 1 · newest first

  1. Premature Onset of Cardiovascular Disease in HIV-Infected Individuals: The Drugs and the VirusHIV Therapy · 2010
  2. The Intersection Between HIV and Syphilis in Men Who Have Sex with Men: Some Fresh PerspectivesHIV Therapy · 2010
  3. Switching Antiretroviral Therapy to Minimize Metabolic ComplicationsHIV Therapy · 2010
  4. Implementation of Cervical Cancer Prevention Services for HIV-Infected Women in Zambia: Measuring Program EffectivenessHIV Therapy · 2010
  5. Lymph Node Involution, T-Cell Adaptation and T-Cell Death in HIV InfectionHIV Therapy · 2010
  6. Regulatory T Cells in HIV ImmunotherapyHIV Therapy · 2010
  7. HIV-Related LymphomaHIV Therapy · 2010
  8. HIV-Related Cryptococcal Meningitis in Resource-Limited SettingsHIV Therapy · 2010
  9. Immune Reconstitution Inflammatory Syndrome in HIV-Positive Patients: A Relatively New and Not Fully Understood PhenomenonHIV Therapy · 2010
  10. Clinical Use of Raltegravir: A ReviewHIV Therapy · 2010
  11. Noninfectious HIV-Related Comorbidities and Haart Toxicities: Choosing Alternative Antiretroviral StrategiesHIV Therapy · 2010
  12. On the Growing Complexity of HIV-1 VaccinesHIV Therapy · 2010
  13. Treatment and Prevention of Cytomegalovirus-Associated Diseases in HIV-1 Infection in the Era of HAARTHIV Therapy · 2010
  14. Effect of Maternal HIV Infection on Measles Susceptibility During Early Infancy: Implications for Optimizing Protection of the InfantHIV Therapy · 2010
  15. Innate Immune Natural Killer Cells and Their Role in HIV and SIV InfectionHIV Therapy · 2010
  16. HIV Treatment in US PrisonsHIV Therapy · 2010
  17. HIV Diagnostics: Challenges and OpportunitiesHIV Therapy · 2010
  18. Micronutrients and HIV InfectionHIV Therapy · 2010
  19. Dual Infection with Hiv-1 and Hiv-2: Double Trouble or Destructive Interference?HIV Therapy · 2010
  20. Genotypic Determination of Hiv-1 Tropism in the Clinical SettingHIV Therapy · 2010
  21. 8Th European Hiv Drug Resistance WorkshopHIV Therapy · 2010
  22. Management of Oropharyngeal and Esophageal Candidiasis in Patients with Hiv InfectionHIV Therapy · 2010
  23. Comparison of Scales to Evaluate the Progression of Hiv-Associated Neurocognitive DisorderHIV Therapy · 2010
  24. Possible Applications for Replicating Hiv-1 VectorsHIV Therapy · 2010
  25. Tenofovir Disoproxil Fumarate and the Kidney in Hiv-Infected Patients: The Evidence Thus FarHIV Therapy · 2010
  26. The Duet Trials: Etravirine in the Management of Treatment-Experienced Hiv-1-Infected PatientsHIV Therapy · 2010
  27. Treatment Considerations for Psychiatric Syndromes Associated with HIV InfectionHIV Therapy · 2010
  28. HIV-Associated Chronic Immune Activation: Current Understandings and Therapeutic InterventionHIV Therapy · 2010
  29. Polygyny, Concurrency, Its Impact and Lack of Impact on HIVHIV Therapy · 2010
  30. Successes and Challenges of HIV Treatment Programs in Haiti: Aftermath of the EarthquakeHIV Therapy · 2010
  31. The Nucleocapsid Protein of HIV-1 as a Promising Therapeutic Target for Antiviral DrugsHIV Therapy · 2010
  32. Lessons from Viral Latency in T Cells: Manipulating HIV-1 Transcription by SirnaHIV Therapy · 2010
  33. Psychiatric Illness, Access and Adherence to Haart: A Brief Review of Recent Findings and Implications for CareHIV Therapy · 2010
  34. Measurement of Antiretroviral Drugs in the Lungs of HIV-Infected PatientsHIV Therapy · 2010
  35. Mhc-I-Restricted HIV Epitope Processing, Immune Control and Immunogen DesignHIV Therapy · 2009
  36. Protein Arginine Methylation: A Pivotal Factor and a Target for Novel HIV-Therapeutics, Other Viruses and Multiple DiseasesHIV Therapy · 2009
  37. Indian Manufacture of New Generic Antiretrovirals: Implications for Global Access to Anti-Hiv DrugsHIV Therapy · 2009
  38. Strategies and Approaches to Purge the Latent Reservoir of HIVHIV Therapy · 2009
  39. Yellow Fever Vaccination in HIV-Infected PatientsHIV Therapy · 2009
  40. T-Cell Dysfunction in HIV-1 Infection: Targeting the InhibitorsHIV Therapy · 2009
  41. Obstructive Lung Disease and Hiv/Aids in the Haart EraHIV Therapy · 2009
  42. Role of the Cd4 Count in HIV ManagementHIV Therapy · 2009
  43. The K65R Mutation in HIV-1 Reverse Transcriptase: Genetic Barriers, Resistance Profile and Clinical ImplicationsHIV Therapy · 2009
  44. Severe Acute Malnutrition and HIV in African ChildrenHIV Therapy · 2009
  45. Designing Immunity to Hiv: Manipulating Antibody-Dependent Cellular Cytotoxicity AntibodiesHIV Therapy · 2009
  46. Pharmacokinetics of HIV Non-Nucleoside Reverse-Transcriptase InhibitorsHIV Therapy · 2009
  47. Vaccination of HIV-Infected AdultsHIV Therapy · 2009
  48. Antiretroviral Therapy in Malaysia: Identifying Barriers to Universal AccessHIV Therapy · 2009
  49. Rethinking the Role of the Local Community in HIV Epidemic Spread in Sub-Saharan Africa: A Proximate-Determinants ApproachHIV Therapy · 2009
  50. Adult Combination Antiretroviral Therapy in Sub-Saharan Africa: Lessons from Botswana and Future ChallengesHIV Therapy · 2009